Phase III study of adjuvant encorafenib plus binimetinib versus placebo in fully resected stage IIB/C BRAFV600-mutated melanoma: COLUMBUS-AD study design
Authors
Atkinson, V. G.Hauschild, A.
Long, G. V.
Mandala, M.
Kicinski, M.
Govaerts, A. S.
Klauck, I.
Ouali, M.
Lorigan, Paul C
Eggermont, A. M. M.
van Akkooi, A. C. J.
Affiliation
University of Queensland, Princess Alexandra & Greenslopes PrivateHospital,Brisbane,QLD,AustraliaIssue Date
2022